Israel - englanti - Ministry of Health

abic marketing ltd, israel - epinephrine as bitartrate; lidocaine hydrochloride - solution for injection - lidocaine hydrochloride 36 mg / 1.8 ml; epinephrine as bitartrate 22.5 mcg / 1.8 ml - lidocaine, combinations - anesthetics, local - production of local anasthesia by nerve-block infiltration technique.

Israel - englanti - Ministry of Health

abic marketing ltd, israel - finasteride - film coated tablets - finasteride 1 mg - finasteride - finasteride - finasteride teva 1 mg is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.

Israel - englanti - Ministry of Health

abic marketing ltd, israel - lorcaserin hydrochloride hemihydrate - film coated tablets - lorcaserin hydrochloride hemihydrate 10.4 mg - lorcaserin - belviq is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (bmi) of:• 30 kg/m2 or greater (obese), or • 27 kg/m2 or greater (overweight) in the presence of at least one weight related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes)

Israel - englanti - Ministry of Health

abic marketing ltd, israel - acitretin - capsules - acitretin 10 mg - acitretin - severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.

Israel - englanti - Ministry of Health

abic marketing ltd, israel - acitretin - capsules - acitretin 25 mg - acitretin - severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.

Israel - englanti - Ministry of Health

abic marketing ltd, israel - deutetrabenazine - tablets extended release - deutetrabenazine 12 mg - austedo is indicated in adults for the treatment of: • chorea associated with huntington’s disease • tardive dyskinesia

Israel - englanti - Ministry of Health

abic marketing ltd, israel - deutetrabenazine - tablets extended release - deutetrabenazine 6 mg - austedo is indicated in adults for the treatment of: • chorea associated with huntington’s disease • tardive dyskinesia

Israel - englanti - Ministry of Health

abic marketing ltd, israel - deutetrabenazine - tablets extended release - deutetrabenazine 9 mg - austedo is indicated in adults for the treatment of: • chorea associated with huntington’s disease • tardive dyskinesia

Israel - englanti - Ministry of Health

abic marketing ltd, israel - pemetrexed - powder for concentrate for solution for infusion - pemetrexed 100 mg - pemetrexed - malignant pleural mesothelioma :pemetrexed teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. non-small cell lung cancer: pemetrexed teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Israel - englanti - Ministry of Health

abic marketing ltd, israel - pemetrexed - powder for concentrate for solution for infusion - pemetrexed 1000 mg - pemetrexed - malignant pleural mesothelioma :pemetrexed teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. non-small cell lung cancer: pemetrexed teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.